Molecure S.A. (MOC.WA)

PLN 8.5

(0.0%)

Total Liabilities Summary of Molecure S.A.

Molecure S.A.'s latest annual total liabilities in 2023 was 11.34 Million PLN , down -2.31% from previous year.
Molecure S.A.'s latest quarterly total liabilities in 2024 Q3 was 7.62 Million PLN , down -18.49% from previous quarter.
Molecure S.A. reported annual total liabilities of 11.61 Million PLN in 2022, up 11.16% from previous year.
Molecure S.A. reported annual total liabilities of 10.44 Million PLN in 2021, up 3.49% from previous year.
Molecure S.A. reported quarterly total liabilities of 9.35 Million PLN for 2024 Q2, down -36.36% from previous quarter.
Molecure S.A. reported quarterly total liabilities of 7.62 Million PLN for 2024 Q3, down -18.49% from previous quarter.

Annual Total Liabilities Chart of Molecure S.A. (2023 - 2014)

Historical Annual Total Liabilities of Molecure S.A. (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	11.34 Million PLN	-2.31%
2022	11.61 Million PLN	11.16%
2021	10.44 Million PLN	3.49%
2020	10.09 Million PLN	53.94%
2019	6.55 Million PLN	59.0%
2018	4.12 Million PLN	-14.91%
2017	4.84 Million PLN	93.3%
2016	2.5 Million PLN	129.4%
2015	1.09 Million PLN	95.19%
2014	560.04 Thousand PLN	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	14.69 Million PLN	29.51%
2024 Q2	9.35 Million PLN	-36.36%
2024 Q3	7.62 Million PLN	-18.49%
2023 Q2	8.2 Million PLN	-9.87%
2023 Q3	11.4 Million PLN	38.96%
2023 Q4	11.34 Million PLN	-0.53%
2023 FY	11.34 Million PLN	-2.31%
2023 Q1	9.1 Million PLN	-21.58%
2022 Q3	8.87 Million PLN	9.67%
2022 Q2	8.09 Million PLN	-16.02%
2022 FY	11.61 Million PLN	11.16%
2022 Q1	9.64 Million PLN	-7.72%
2022 Q4	11.61 Million PLN	30.79%
2021 Q4	10.44 Million PLN	31.04%
2021 Q3	7.97 Million PLN	-18.12%
2021 Q2	9.73 Million PLN	11.14%
2021 FY	10.44 Million PLN	3.49%
2021 Q1	8.76 Million PLN	-13.22%
2020 Q1	5.42 Million PLN	-17.27%
2020 Q2	6.3 Million PLN	16.26%
2020 FY	10.09 Million PLN	53.94%
2020 Q4	10.09 Million PLN	107.3%
2020 Q3	4.86 Million PLN	-22.8%
2019 Q4	6.55 Million PLN	29.94%
2019 FY	6.55 Million PLN	59.0%
2019 Q3	5.04 Million PLN	-6.36%
2019 Q2	5.38 Million PLN	-9.1%
2019 Q1	5.92 Million PLN	43.75%
2018 Q4	4.12 Million PLN	333.11%
2018 FY	4.12 Million PLN	-14.91%
2018 Q1	2.65 Million PLN	-45.22%
2018 Q2	3.46 Million PLN	30.48%
2018 Q3	952.27 Thousand PLN	-72.51%
2017 Q2	1.86 Million PLN	0.0%
2017 FY	4.84 Million PLN	93.3%
2017 Q3	2.4 Million PLN	29.01%
2017 Q4	4.84 Million PLN	101.31%
2017 Q1	- PLN	-100.0%
2016 Q4	2.5 Million PLN	0.0%
2016 FY	2.5 Million PLN	129.4%
2016 Q1	- PLN	0.0%
2015 FY	1.09 Million PLN	95.19%
2014 FY	560.04 Thousand PLN	0.0%

Peer Total Liabilities Comparison of Molecure S.A.

Name	Total Liabilities	Total Liabilities Difference
Bioceltix S.A.	2.26 Million PLN	-400.08%
BIOTON S.A.	215.86 Million PLN	94.745%
Captor Therapeutics Spolka Akcyjna	28.07 Million PLN	59.59%
Mabion S.A.	90.47 Million PLN	87.461%
NanoGroup S.A.	1.49 Million PLN	-661.34%
Pharmena S.A.	1.9 Million PLN	-495.21%
Poltreg S.A.	39.58 Million PLN	71.338%
Pure Biologics Spólka Akcyjna	20.84 Million PLN	45.576%
Ryvu Therapeutics S.A.	120.36 Million PLN	90.574%
Synthaverse S.A.	153.26 Million PLN	92.598%
Urteste S.A.	1.85 Million PLN	-511.574%